Perrigo Company plc (PRGO)
NYSE: PRGO · IEX Real-Time Price · USD
32.79
-0.27 (-0.82%)
May 3, 2024, 4:00 PM EDT - Market closed
Perrigo Company Revenue
In the year 2023, Perrigo Company had annual revenue of $4.66B with 4.58% growth. Revenue in the quarter ending December 31, 2023 was $1.16B with 0.14% year-over-year growth.
Revenue (ttm)
$4.66B
Revenue Growth
+4.58%
P/S Ratio
0.95
Revenue / Employee
$509,365
Employees
9,140
Market Cap
4.44B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4.66B | 204.00M | 4.58% |
Dec 31, 2022 | 4.45B | 312.90M | 7.56% |
Dec 31, 2021 | 4.14B | 50.50M | 1.24% |
Dec 31, 2020 | 4.09B | 218.30M | 5.64% |
Dec 31, 2019 | 3.87B | -861.80M | -18.21% |
Dec 31, 2018 | 4.73B | -214.50M | -4.34% |
Dec 31, 2017 | 4.95B | -334.40M | -6.33% |
Dec 31, 2016 | 5.28B | 1.05B | 24.92% |
Jun 27, 2015 | 4.23B | 313.00M | 8.00% |
Jun 28, 2014 | 3.91B | 374.30M | 10.57% |
Jun 29, 2013 | 3.54B | 366.60M | 11.55% |
Jun 30, 2012 | 3.17B | 418.20M | 15.18% |
Jun 25, 2011 | 2.76B | 486.85M | 21.46% |
Jun 26, 2010 | 2.27B | 262.56M | 13.09% |
Jun 27, 2009 | 2.01B | 275.67M | 15.94% |
Jun 28, 2008 | 1.73B | 361.57M | 26.42% |
Jun 30, 2007 | 1.37B | 1.53M | 0.11% |
Jul 1, 2006 | 1.37B | 342.72M | 33.47% |
Jun 25, 2005 | 1.02B | 125.89M | 14.02% |
Jun 26, 2004 | 898.20M | 64.10M | 7.69% |
Jun 28, 2003 | 834.10M | -963.00K | -0.12% |
Jun 29, 2002 | 835.06M | 81.58M | 10.83% |
Jun 30, 2001 | 753.49M | 9.20M | 1.24% |
Jul 1, 2000 | 744.28M | -153.23M | -17.07% |
Jul 3, 1999 | 897.52M | -5.12M | -0.57% |
Jun 30, 1998 | 902.64M | 58.05M | 6.87% |
Jun 30, 1997 | 844.59M | 66.47M | 8.54% |
Jun 30, 1996 | 778.12M | 61.04M | 8.51% |
Jun 30, 1995 | 717.08M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Select Medical Holdings | 6.79B |
Alkermes | 1.73B |
Merit Medical Systems | 1.28B |
Doximity | 468.33M |
CRISPR Therapeutics AG | 371.21M |
TransMedics Group | 296.92M |
Alpine Immune Sciences | 58.88M |
Krystal Biotech | 50.70M |
PRGO News
- 4 days ago - Perrigo Announces Quarterly Dividend - PRNewsWire
- 10 days ago - Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million - PRNewsWire
- 12 days ago - Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024 - PRNewsWire
- 4 weeks ago - CVS Caremark to cover Perrigo's birth control pill in US at zero cost for plan sponsors - Reuters
- 2 months ago - Perrigo Commences Shipments of Opill® to Retailers Nationwide, Empowering Millions to Enter a New Era of Reproductive Health Access in the United States - PRNewsWire
- 2 months ago - Perrigo to Attend UBS Global Consumer and Retail Conference - PRNewsWire
- 2 months ago - Perrigo Reports Fourth Quarter & Fiscal Year 2023 Financial Results From Continuing Operations; Launches Investment & Efficiency Program - PRNewsWire
- 2 months ago - Perrigo Increases its Quarterly Dividend - PRNewsWire